Creative Medical Technology Holdings (CELZ) Current Assets (2010 - 2026)
Creative Medical Technology Holdings' (CELZ) quarterly Current Assets came in at $9.0 million in Q2 2026, up 35.98% year-over-year from $6.6 million in Q2 2025, and up 48.85% quarter-over-quarter from $6.1 million in Q1 2026.
Analysis
Creative Medical Technology Holdings (CELZ) Current Assets (2010 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Current Assets for 17 consecutive years, with $9.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Assets rose 35.98% year-over-year to $9.0 million in Q2 2026; TTM through Jun 2026 was $9.0 million, a 35.98% increase from a year earlier, with the FY2025 full-year figure at $7.4 million, up 20.6% from the prior year.
- Current Assets was $9.0 million for Q2 2026 at Creative Medical Technology Holdings, up from $6.1 million in the prior quarter.
- Over five years, Current Assets peaked at $22.9 million in Q2 2022 and troughed at $5.4 million in Q3 2025.
- A 5-year average of $10.9 million and a median of $9.1 million in 2024 frame the typical range for Current Assets.
- Across the five-year window, Current Assets soared 14370.99% in 2022 and tumbled 47.43% in 2024, its largest moves.
- Over 5 years, Current Assets stood at $18.7 million in 2022, then sank by 45.21% to $10.3 million in 2023, then slumped by 40.27% to $6.1 million in 2024, then grew by 20.6% to $7.4 million in 2025, then rose by 21.89% to $9.0 million in 2026.
- The last three Current Assets figures came in at $9.0 million (Q2 2026), $6.1 million (Q1 2026), and $7.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 1.06 Bn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 2.37 Bn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 464.26 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 1.23 Bn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 834.27 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 1.18 Bn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 134.38 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 2.22 Bn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 264.73 Mn |
| 10 | Creative Medical Technology Holdings | 1.48 Mn | 1.50 Mn | - | 9.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.02 Mn |
| Mar 31, 2026 | 6.06 Mn |
| Dec 31, 2025 | 7.40 Mn |
| Sep 30, 2025 | 5.41 Mn |
| Jun 30, 2025 | 6.63 Mn |
| Mar 31, 2025 | 7.84 Mn |
| Dec 31, 2024 | 6.14 Mn |
| Sep 30, 2024 | 6.33 Mn |
| Jun 30, 2024 | 7.60 Mn |
| Mar 31, 2024 | 9.20 Mn |
| Dec 31, 2023 | 10.27 Mn |
| Sep 30, 2023 | 12.04 Mn |
| Jun 30, 2023 | 13.73 Mn |
| Mar 31, 2023 | 14.81 Mn |
| Dec 31, 2022 | 18.75 Mn |
| Sep 30, 2022 | 22.01 Mn |
| Jun 30, 2022 | 22.95 Mn |
| Mar 31, 2022 | 9.23 Mn |
| Dec 31, 2021 | 10.74 Mn |
| Sep 30, 2021 | 2.58 Mn |